Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies
INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond...
Ausführliche Beschreibung
Autor*in: |
Mustafa Karadeniz [verfasserIn] Azize Cemre Öztürk [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch ; Türkisch |
Erschienen: |
2023 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Boğaziçi Tıp Dergisi - Kare Publishing, 2020, 10(2023), 3, Seite 168-173 |
---|---|
Übergeordnetes Werk: |
volume:10 ; year:2023 ; number:3 ; pages:168-173 |
Links: |
---|
DOI / URN: |
10.14744/bmj.2023.63308 |
---|
Katalog-ID: |
DOAJ100263674 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ100263674 | ||
003 | DE-627 | ||
005 | 20240414090544.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240414s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.14744/bmj.2023.63308 |2 doi | |
035 | |a (DE-627)DOAJ100263674 | ||
035 | |a (DE-599)DOAJ05715b5bf21d4f078fad221723549e8c | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a tur | ||
100 | 0 | |a Mustafa Karadeniz |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported. | ||
650 | 4 | |a amnioinfusion | |
650 | 4 | |a meconium | |
650 | 4 | |a meconium aspiration syndrome. | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Azize Cemre Öztürk |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Boğaziçi Tıp Dergisi |d Kare Publishing, 2020 |g 10(2023), 3, Seite 168-173 |w (DE-627)1735239631 |x 21490287 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2023 |g number:3 |g pages:168-173 |
856 | 4 | 0 | |u https://doi.org/10.14744/bmj.2023.63308 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/05715b5bf21d4f078fad221723549e8c |z kostenfrei |
856 | 4 | 0 | |u https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-63308 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2149-0287 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 10 |j 2023 |e 3 |h 168-173 |
author_variant |
m k mk a c ö acö |
---|---|
matchkey_str |
article:21490287:2023----::eaadaenlfetoanonuinpledrndlvrioioyrmitc |
hierarchy_sort_str |
2023 |
publishDate |
2023 |
allfields |
10.14744/bmj.2023.63308 doi (DE-627)DOAJ100263674 (DE-599)DOAJ05715b5bf21d4f078fad221723549e8c DE-627 ger DE-627 rakwb eng tur Mustafa Karadeniz verfasserin aut Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported. amnioinfusion meconium meconium aspiration syndrome. Medicine R Azize Cemre Öztürk verfasserin aut In Boğaziçi Tıp Dergisi Kare Publishing, 2020 10(2023), 3, Seite 168-173 (DE-627)1735239631 21490287 nnns volume:10 year:2023 number:3 pages:168-173 https://doi.org/10.14744/bmj.2023.63308 kostenfrei https://doaj.org/article/05715b5bf21d4f078fad221723549e8c kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-63308 kostenfrei https://doaj.org/toc/2149-0287 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2023 3 168-173 |
spelling |
10.14744/bmj.2023.63308 doi (DE-627)DOAJ100263674 (DE-599)DOAJ05715b5bf21d4f078fad221723549e8c DE-627 ger DE-627 rakwb eng tur Mustafa Karadeniz verfasserin aut Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported. amnioinfusion meconium meconium aspiration syndrome. Medicine R Azize Cemre Öztürk verfasserin aut In Boğaziçi Tıp Dergisi Kare Publishing, 2020 10(2023), 3, Seite 168-173 (DE-627)1735239631 21490287 nnns volume:10 year:2023 number:3 pages:168-173 https://doi.org/10.14744/bmj.2023.63308 kostenfrei https://doaj.org/article/05715b5bf21d4f078fad221723549e8c kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-63308 kostenfrei https://doaj.org/toc/2149-0287 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2023 3 168-173 |
allfields_unstemmed |
10.14744/bmj.2023.63308 doi (DE-627)DOAJ100263674 (DE-599)DOAJ05715b5bf21d4f078fad221723549e8c DE-627 ger DE-627 rakwb eng tur Mustafa Karadeniz verfasserin aut Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported. amnioinfusion meconium meconium aspiration syndrome. Medicine R Azize Cemre Öztürk verfasserin aut In Boğaziçi Tıp Dergisi Kare Publishing, 2020 10(2023), 3, Seite 168-173 (DE-627)1735239631 21490287 nnns volume:10 year:2023 number:3 pages:168-173 https://doi.org/10.14744/bmj.2023.63308 kostenfrei https://doaj.org/article/05715b5bf21d4f078fad221723549e8c kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-63308 kostenfrei https://doaj.org/toc/2149-0287 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2023 3 168-173 |
allfieldsGer |
10.14744/bmj.2023.63308 doi (DE-627)DOAJ100263674 (DE-599)DOAJ05715b5bf21d4f078fad221723549e8c DE-627 ger DE-627 rakwb eng tur Mustafa Karadeniz verfasserin aut Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported. amnioinfusion meconium meconium aspiration syndrome. Medicine R Azize Cemre Öztürk verfasserin aut In Boğaziçi Tıp Dergisi Kare Publishing, 2020 10(2023), 3, Seite 168-173 (DE-627)1735239631 21490287 nnns volume:10 year:2023 number:3 pages:168-173 https://doi.org/10.14744/bmj.2023.63308 kostenfrei https://doaj.org/article/05715b5bf21d4f078fad221723549e8c kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-63308 kostenfrei https://doaj.org/toc/2149-0287 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2023 3 168-173 |
allfieldsSound |
10.14744/bmj.2023.63308 doi (DE-627)DOAJ100263674 (DE-599)DOAJ05715b5bf21d4f078fad221723549e8c DE-627 ger DE-627 rakwb eng tur Mustafa Karadeniz verfasserin aut Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported. amnioinfusion meconium meconium aspiration syndrome. Medicine R Azize Cemre Öztürk verfasserin aut In Boğaziçi Tıp Dergisi Kare Publishing, 2020 10(2023), 3, Seite 168-173 (DE-627)1735239631 21490287 nnns volume:10 year:2023 number:3 pages:168-173 https://doi.org/10.14744/bmj.2023.63308 kostenfrei https://doaj.org/article/05715b5bf21d4f078fad221723549e8c kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-63308 kostenfrei https://doaj.org/toc/2149-0287 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2023 3 168-173 |
language |
English Turkish |
source |
In Boğaziçi Tıp Dergisi 10(2023), 3, Seite 168-173 volume:10 year:2023 number:3 pages:168-173 |
sourceStr |
In Boğaziçi Tıp Dergisi 10(2023), 3, Seite 168-173 volume:10 year:2023 number:3 pages:168-173 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
amnioinfusion meconium meconium aspiration syndrome. Medicine R |
isfreeaccess_bool |
true |
container_title |
Boğaziçi Tıp Dergisi |
authorswithroles_txt_mv |
Mustafa Karadeniz @@aut@@ Azize Cemre Öztürk @@aut@@ |
publishDateDaySort_date |
2023-01-01T00:00:00Z |
hierarchy_top_id |
1735239631 |
id |
DOAJ100263674 |
language_de |
englisch türkisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ100263674</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414090544.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14744/bmj.2023.63308</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ100263674</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ05715b5bf21d4f078fad221723549e8c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">tur</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Mustafa Karadeniz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation &gt;2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">amnioinfusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">meconium</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">meconium aspiration syndrome.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Azize Cemre Öztürk</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Boğaziçi Tıp Dergisi</subfield><subfield code="d">Kare Publishing, 2020</subfield><subfield code="g">10(2023), 3, Seite 168-173</subfield><subfield code="w">(DE-627)1735239631</subfield><subfield code="x">21490287</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:168-173</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14744/bmj.2023.63308</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/05715b5bf21d4f078fad221723549e8c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-63308</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2149-0287</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2023</subfield><subfield code="e">3</subfield><subfield code="h">168-173</subfield></datafield></record></collection>
|
author |
Mustafa Karadeniz |
spellingShingle |
Mustafa Karadeniz misc amnioinfusion misc meconium misc meconium aspiration syndrome. misc Medicine misc R Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies |
authorStr |
Mustafa Karadeniz |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1735239631 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut |
collection |
DOAJ |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
21490287 |
topic_title |
Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies amnioinfusion meconium meconium aspiration syndrome |
topic |
misc amnioinfusion misc meconium misc meconium aspiration syndrome. misc Medicine misc R |
topic_unstemmed |
misc amnioinfusion misc meconium misc meconium aspiration syndrome. misc Medicine misc R |
topic_browse |
misc amnioinfusion misc meconium misc meconium aspiration syndrome. misc Medicine misc R |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Boğaziçi Tıp Dergisi |
hierarchy_parent_id |
1735239631 |
hierarchy_top_title |
Boğaziçi Tıp Dergisi |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1735239631 |
title |
Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies |
ctrlnum |
(DE-627)DOAJ100263674 (DE-599)DOAJ05715b5bf21d4f078fad221723549e8c |
title_full |
Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies |
author_sort |
Mustafa Karadeniz |
journal |
Boğaziçi Tıp Dergisi |
journalStr |
Boğaziçi Tıp Dergisi |
lang_code |
eng tur |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2023 |
contenttype_str_mv |
txt |
container_start_page |
168 |
author_browse |
Mustafa Karadeniz Azize Cemre Öztürk |
container_volume |
10 |
format_se |
Elektronische Aufsätze |
author-letter |
Mustafa Karadeniz |
doi_str_mv |
10.14744/bmj.2023.63308 |
author2-role |
verfasserin |
title_sort |
fetal and maternal effects of amnioinfusion applied during delivery in oligohydramniotic meconium- stained pregnancies |
title_auth |
Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies |
abstract |
INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported. |
abstractGer |
INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported. |
abstract_unstemmed |
INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation >2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
3 |
title_short |
Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies |
url |
https://doi.org/10.14744/bmj.2023.63308 https://doaj.org/article/05715b5bf21d4f078fad221723549e8c https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-63308 https://doaj.org/toc/2149-0287 |
remote_bool |
true |
author2 |
Azize Cemre Öztürk |
author2Str |
Azize Cemre Öztürk |
ppnlink |
1735239631 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.14744/bmj.2023.63308 |
up_date |
2024-07-03T13:42:59.353Z |
_version_ |
1803565588135542784 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ100263674</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414090544.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14744/bmj.2023.63308</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ100263674</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ05715b5bf21d4f078fad221723549e8c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">tur</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Mustafa Karadeniz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Fetal and Maternal Effects of Amnioinfusion Applied during Delivery in Oligohydramniotic Meconium- Stained Pregnancies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">INTRODUCTION: This study aimed to investigate the fetal and maternal effects of amnioinfusion applied during delivery in meconium-stained pregnancies. METHODS: Sixty singleton pregnancies with cervical dilation &gt;2 cm, normal fetal heart rate, and amniotic fluid index below 5 cm, at or beyond 37 weeks of gestation were included in this study. Thirty patients were randomly assigned to the amnioinfusion group and the other 30 patients formed the control group. RESULTS: After amnioinfusion was applied to both groups, maternal fever, fetal tachycardia, fetal heart rate tracings, operation rates, Apgar scores, presence of meconium under vocal cords and oropharynx, and incidence of meconium aspiration syndrome (MAS) were evaluated. Patients requiring operative intervention due to fetal distress were 3% (1/30) in Group 1 and 37% (11/30) in Group 2, which was statistically significant (p=0.002). Apgar scores below 7 at 1 min in Group 1 was 10% (3/30), while it was 40% (12/30) in Group 2, which was statistically significant (p=0.01). In Group 1, no infants had an Apgar score below 7 at 5 min, while in Group 2, 24% (7/30) of infants had an Apgar score below 7, which was statistically significant (p=0.01). Meconium under the oropharynx was found to be 24% (7/30) in Group 1 and 70% (21/30) in Group 2, while the presence of meconium under the vocal cords was 6% (2/30) in Group 1 and 44% (13/30) in Group 2, and both of these differences were statistically significant (p=0.0006, p=0.002). The incidence of MAS observed in Group 1 was 0 and 20% (6/30) in Group 2, which was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Amnioinfusion is one of a series of interventions aimed at reducing mortality and morbidity related to meconium aspiration. Although our clinical study showed positive results, randomized controlled trials, and meta-analyses are needed to clarify whether routine amnioinfusion provides clinical benefits, and prospective randomized controlled studies should be supported.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">amnioinfusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">meconium</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">meconium aspiration syndrome.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Azize Cemre Öztürk</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Boğaziçi Tıp Dergisi</subfield><subfield code="d">Kare Publishing, 2020</subfield><subfield code="g">10(2023), 3, Seite 168-173</subfield><subfield code="w">(DE-627)1735239631</subfield><subfield code="x">21490287</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:168-173</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14744/bmj.2023.63308</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/05715b5bf21d4f078fad221723549e8c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-63308</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2149-0287</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2023</subfield><subfield code="e">3</subfield><subfield code="h">168-173</subfield></datafield></record></collection>
|
score |
7.398493 |